One stop shop for clinical trials open for business

September 21, 2005

Australians will be able to search for global information on the clinical trials of new medicines and vaccines, through a pioneering website unveiled overnight in Geneva.

"This is an extraordinary resource for anyone interested in discovering just what sort of data is out there on potentially life-saving medicines and vaccines," the Chief Executive Officer of Medicines Australia, Kieran Schneemann, said today.

"There is clear interest from doctors, patients and their carers in finding out what clinical trials have been conducted into particular illnesses, and what is presently underway. The industry has responded and it is important others do the same."

This is the first ever internet search engine constructed specifically to link to available online information about completed and ongoing clinical trials conducted worldwide.

The IFPMA Clinical Trial Portal can be found at

IFPMA is the International Federation of Pharmaceutical Manufacturers and Associations, and the search engine which currently has more than 250,000 links was developed in conjunction with IBM.

In the global research and development pipeline, the pharmaceutical industry is working on more than 700 new medicines and vaccines for diseases such as HIV/AIDS, cancer, heart disease, stroke and osteoporosis.

A number of sources will be tapped by the search engine. They include government sites, pharmaceutical industry association sites, and those run by individual pharmaceutical companies or other parties working on their behalf.

IFPMA proposes that two broad types of information can be searched for. One involves listings or registries of ongoing clinical trials, where basic information such as title, description in lay terms, trial phase, type, status and purpose, condition or disease, eligibility criteria such as age or gender, location of trial and contact information can be found.

The other involves clinical trial results, which are made available in a standard summary format by various online databases.

"This website shows how seriously the industry takes its commitment to transparency and reflects the industry's effort to provide doctors, patients and carers with as much information about its medicines as possible," Mr Schneemann said.
CONTACT: Paul Chamberlin 61 419 233 989

Research Australia

Related Clinical Trials Articles from Brightsurf:

Nearly 1 in 5 cancer patients less likely to enroll in clinical trials during pandemic
A significant portion of cancer patients may be less likely to enroll in a clinical trial due to the ongoing coronavirus pandemic.

COVID-19 clinical trials lack diversity
Despite disproportionately higher rates of COVID-19 infection, hospitalization and death among people of color, minority groups are significantly underrepresented in COVID-19 clinical trials.

Why we should trust registered clinical trials
In a time when we have to rely on clinical trials for COVID-19 drugs and vaccines, a new study brings good news about the credibility of registered clinical trials.

Inclusion of children in clinical trials of treatments for COVID-19
This Viewpoint discusses the exclusion of children from coronavirus disease 2019 (COVID-19) clinical trials and why that could harm treatment options for children.

Review evaluates how AI could boost the success of clinical trials
In a review publishing July 17, 2019 in the journal Trends in Pharmacological Sciences, researchers examined how artificial intelligence (AI) could affect drug development in the coming decade.

Kidney patients are neglected in clinical trials
The exclusion of patients with kidney diseases from clinical trials remains an unsolved problem that hinders optimal care of these patients.

Clinical trials beginning for possible preeclampsia treatment
For over 20 years, a team of researchers at Lund University has worked on developing a drug against preeclampsia -- a serious disorder which annually affects around 9 million pregnant women worldwide and is one of the main causes of death in both mothers and unborn babies.

Underenrollment in clinical trials: Patients not the problem
The authors of the study published this month in the Journal of Clinical Oncology investigated why many cancer clinical trials fail to enroll enough patients.

When designing clinical trials for huntington's disease, first ask the experts
Progress in understanding the genetic mutation responsible for Huntington's disease (HD) and at least some molecular underpinnings of the disease has resulted in a new era of clinical testing of potential treatments.

New ALS therapy in clinical trials
New research led by Washington University School of Medicine in St.

Read More: Clinical Trials News and Clinical Trials Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to